{name}
{subtitle}
A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)
city
~45 mi. (Kraków, Poland, +93 more cities)
facility
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - O-Klinika Onkologii Klinicznej ( Site 240
drug
belzutifan, +1 more drug
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)
city
~45 mi. (Kraków, Poland, +150 more cities)
facility
Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie ( Site 0905)
drug
cisplatin, +2 more drugs
drug type
chemotherapy, +2 more types
Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)
city
~45 mi. (Kraków, Poland, +137 more cities)
facility
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Oddzial w Krakowie ( Site 0959)
A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (LEAP-010) (MK-7902-010)
city
~45 mi. (Kraków, Poland, +127 more cities)
facility
Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie ( Site 2502)
drug
lenvatinib, +1 more drug
drug type
immunotherapy, +1 more type
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992)
city
~45 mi. (Kraków, Poland, +92 more cities)
facility
Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie ( Site 0153)
drug
chemotherapy, +2 more drugs
drug type
chemotherapy, +2 more types
Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or II Non-Small Cell Lung Cancer (NSCLC) (MK-3475-867/KEYNOTE-867)
city
~45 mi. (Kraków, Poland, +145 more cities)
facility
Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie ( Site 2400)
drug
pembrolizumab, +1 more drug
drug type
immunotherapy, +2 more types
Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC)
city
~45 mi. (Kraków, Poland, +62 more cities)
facility
Pratia MCM Krakow
biomarker
ER Negative, +2 more biomarkers
drug
carboplatin, +2 more drugs
drug type
chemotherapy, +1 more type
A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
city
~45 mi. (Kraków, Poland, +44 more cities)
facility
Pratia MCM Krakow
biomarker
BCL2 Fusion, +2 more biomarkers
condition
Diffuse Large B-Cell Lymphoma, +3 more conditions
drug
cisplatin, +5 more drugs
drug type
chemotherapy, +3 more types